Article
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells
19 Aug 2022
Abstract excerpt
Abstract Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by CD8 + cytotoxic T-cells. Clinical studies of latency reversing agents (LRA) in antiretroviral therapy (ART)-treated individuals have shown increases in HIV transcription, but without reductions in virologic measures, or evidence that HIV-specific CD8 + T-cells were productively engaged. Here, we show that the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
